Enovis Corp
NYSE:ENOV

Watchlist Manager
Enovis Corp Logo
Enovis Corp
NYSE:ENOV
Watchlist
Price: 43.03 USD
Market Cap: 2.4B USD
Have any thoughts about
Enovis Corp?
Write Note

Intrinsic Value

The intrinsic value of one ENOV stock under the Base Case scenario is 72.43 USD. Compared to the current market price of 43.03 USD, Enovis Corp is Undervalued by 41%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ENOV Intrinsic Value
72.43 USD
Undervaluation 41%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Enovis Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ENOV cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ENOV?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Enovis Corp

Provide an overview of the primary business activities
of Enovis Corp.

What unique competitive advantages
does Enovis Corp hold over its rivals?

What risks and challenges
does Enovis Corp face in the near future?

Has there been any significant insider trading activity
in Enovis Corp recently?

Summarize the latest earnings call
of Enovis Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Enovis Corp.

Provide P/S
for Enovis Corp.

Provide P/E
for Enovis Corp.

Provide P/OCF
for Enovis Corp.

Provide P/FCFE
for Enovis Corp.

Provide P/B
for Enovis Corp.

Provide EV/S
for Enovis Corp.

Provide EV/GP
for Enovis Corp.

Provide EV/EBITDA
for Enovis Corp.

Provide EV/EBIT
for Enovis Corp.

Provide EV/OCF
for Enovis Corp.

Provide EV/FCFF
for Enovis Corp.

Provide EV/IC
for Enovis Corp.

Show me price targets
for Enovis Corp made by professional analysts.

What are the Revenue projections
for Enovis Corp?

How accurate were the past Revenue estimates
for Enovis Corp?

What are the Net Income projections
for Enovis Corp?

How accurate were the past Net Income estimates
for Enovis Corp?

What are the EPS projections
for Enovis Corp?

How accurate were the past EPS estimates
for Enovis Corp?

What are the EBIT projections
for Enovis Corp?

How accurate were the past EBIT estimates
for Enovis Corp?

Compare the revenue forecasts
for Enovis Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Enovis Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Enovis Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Enovis Corp compared to its peers.

Compare the P/E ratios
of Enovis Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Enovis Corp with its peers.

Analyze the financial leverage
of Enovis Corp compared to its main competitors.

Show all profitability ratios
for Enovis Corp.

Provide ROE
for Enovis Corp.

Provide ROA
for Enovis Corp.

Provide ROIC
for Enovis Corp.

Provide ROCE
for Enovis Corp.

Provide Gross Margin
for Enovis Corp.

Provide Operating Margin
for Enovis Corp.

Provide Net Margin
for Enovis Corp.

Provide FCF Margin
for Enovis Corp.

Show all solvency ratios
for Enovis Corp.

Provide D/E Ratio
for Enovis Corp.

Provide D/A Ratio
for Enovis Corp.

Provide Interest Coverage Ratio
for Enovis Corp.

Provide Altman Z-Score Ratio
for Enovis Corp.

Provide Quick Ratio
for Enovis Corp.

Provide Current Ratio
for Enovis Corp.

Provide Cash Ratio
for Enovis Corp.

What is the historical Revenue growth
over the last 5 years for Enovis Corp?

What is the historical Net Income growth
over the last 5 years for Enovis Corp?

What is the current Free Cash Flow
of Enovis Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Enovis Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Enovis Corp

Current Assets 1.2B
Cash & Short-Term Investments 35m
Receivables 394.7m
Other Current Assets 743m
Non-Current Assets 4.3B
PP&E 446.7m
Intangibles 3.7B
Other Non-Current Assets 88.6m
Current Liabilities 518m
Accounts Payable 159.8m
Accrued Liabilities 268.4m
Other Current Liabilities 89.8m
Non-Current Liabilities 1.6B
Long-Term Debt 1.3B
Other Non-Current Liabilities 308.2m
Efficiency

Earnings Waterfall
Enovis Corp

Revenue
1.9B USD
Cost of Revenue
-817.2m USD
Gross Profit
1.1B USD
Operating Expenses
-1.1B USD
Operating Income
10.3m USD
Other Expenses
-100.8m USD
Net Income
-90.6m USD

Free Cash Flow Analysis
Enovis Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q2 2024, the company reported sales of $525 million, marking a 23% increase year-over-year. Adjusted EBITDA surged by 36% to a 17.2% margin, reflecting a 190 basis points improvement. A major highlight was the integration of Lima, which contributed to a stronger market position and operational synergies. The company has revised its full-year revenue guidance to $2.08 billion to $2.13 billion, with expected adjusted EBITDA between $368 million and $383 million. Adjusted earnings per share were raised to a range of $2.62 to $2.77. Anticipating stronger growth in the second half, particularly with new product launches, the company is confident in delivering robust financial results.

What is Earnings Call?
Fundamental Scores

ENOV Profitability Score
Profitability Due Diligence

Enovis Corp's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
Negative Free Cash Flow
45/100
Profitability
Score

Enovis Corp's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

ENOV Solvency Score
Solvency Due Diligence

Enovis Corp's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
50/100
Solvency
Score

Enovis Corp's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ENOV Price Targets Summary
Enovis Corp

Wall Street analysts forecast ENOV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ENOV is 69.36 USD with a low forecast of 58.58 USD and a high forecast of 78.75 USD.

Lowest
Price Target
58.58 USD
36% Upside
Average
Price Target
69.36 USD
61% Upside
Highest
Price Target
78.75 USD
83% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ENOV?

Click here to dive deeper.

Dividends

Enovis Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for ENOV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ENOV Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Enovis Corp Logo
Enovis Corp

Country

United States of America

Industry

Health Care

Market Cap

2.4B USD

Dividend Yield

0%

Description

Enovis Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Wilmington, Delaware and currently employs 16,200 full-time employees. The company went IPO on 2008-05-08. Enovis Corporation, formerly Colfax Corporation, is a medical technology company that provides orthopedic care and fabrication technology products and services under DJO brand. The Company’s segments include Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Its fabrication technology products are marketed under several brands. The Medical Technology segment develops, manufactures and distributes medical devices and services across the continuum of patient care from injury prevention to joint replacement to the rehabilitation after surgery, injury from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, and others.

Contact

DELAWARE
Wilmington
2711 Centerville Road, Suite 400
+13022529160.0
www.enovis.com

IPO

2008-05-08

Employees

16 200

Officers

CEO & Chairman
Mr. Matthew L. Trerotola
Senior VP & CFO
Mr. Phillip Benjamin Berry
Senior VP & Chief Human Resources Officer
Ms. Patricia A. Lang
Executive Vice President of Strategy & Business Development
Mr. Daniel A. Pryor
Executive Advisor & Director
Mr. Brady R. Shirley
VP, Controller & Chief Accounting Officer
Mr. John Kleckner
Show More
Vice President of Investor Relations
Derek Leckow
Senior VP & Chief Legal Officer
Mr. Bradley J. Tandy
Vice President of Corporate Communication
Katie Sweet
President of U.S. Surgical and Global Product & Enabling Technologies
Mr. Tim Czartoski
Show Less

See Also

Discover More
What is the Intrinsic Value of one ENOV stock?

The intrinsic value of one ENOV stock under the Base Case scenario is 72.43 USD.

Is ENOV stock undervalued or overvalued?

Compared to the current market price of 43.03 USD, Enovis Corp is Undervalued by 41%.

Back to Top